Quantitative analysis for InfuSystem Holdings, Inc. (INFU) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (65.0) (grade B). 28 signals analyzed (23 differentiated alt-data).
INFU stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $10.28 | $9.71 | $9.83 |
| 2026-05-11 | $8.70 | $8.21 | $8.37 |
| 2026-05-21 | $10.15 | $9.61 | $9.94 |
| 2026-06-03 | $9.10 | $8.78 | $9.03 |
| 2026-06-15 | $9.17 | $8.78 | $8.80 |
| 2026-06-26 | $10.27 | $8.96 | $10.05 |
| 2026-07-09 | $9.96 | $9.60 | $9.74 |
| 2026-07-21 | $9.20 | $8.95 | $9.15 |
| 2026-07-31 | $9.44 | $8.88 | $9.14 |
| 2026-08-12 | $12.35 | $12.02 | $12.24 |
| 2026-08-24 | $12.10 | $11.90 | $11.95 |
| 2026-09-03 | $12.47 | $12.00 | $12.18 |
How InfuSystem Holdings, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CNTX | Context Therapeutics Inc. | $205M | — |
| BDTX | Black Diamond Therapeutics, Inc. | $206M | — |
| TENX | Tenax Therapeutics, Inc. | $206M | — |
| NBP | NovaBridge Biosciences | $203M | — |
View all Health Care stocks by valuation and signals →
InfuSystem Holdings, Inc. (INFU) scores Buy (65.0) across 5 measured dimensions, ranging from technicals at 65 down to analyst consensus at 38. The spread of 27 points is narrow enough that no single dimension dominates the composite. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 65 |
| competitive moat | 61 |
| earnings quality | 51 |
| valuation | 46 |
| analyst consensus | 38 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on InfuSystem Holdings, Inc. (INFU): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/INFU"><img src="https://stoquant.com/badge/INFU.svg" alt="InfuSystem Holdings, Inc. (INFU) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.